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1. Introduction 
In the last few years, three-dimensional ultrasound (3D US) imaging has attracted the 
interest among medical imaging researchers, because of its unique ability to provide images 
in three orthogonal planes, and the imaging tool has been proven to be useful clinically in 
the fields of obstetrics, hepatology, cardiology, urology, and mastology (Badea et al., 2007; 
Benacerraf et al., 2006; Tutschek & Sahn, 2007; Taylor et al., 2005; Kotsianos-Hermle et al., 
2009). 
Multiplanar 3D US imaging is thought to provide more spatial information and allow easier 
anatomic assessment than the conventional two-dimensional ultrasound imaging.  Contrast-
enhanced three-dimensional ultrasound (CE 3D US) imaging is a new medical imaging 
technique that uses reflections of microbubbles to clearly depict blood vessels and allows the 
images to be displayed spatially at different visual angles. Although CE 3D US imaging has 
recently been evaluated as a tool for clinical diagnosis (Krenning et al., 2007; Yukisawa et al., 
2007; Ohto et al., 2005; Wessels et al., 2004; Forsberg et al., 2004), only a few studies have 
investigated its usefulness in the assessment of hepatic tumors (Yukisawa et al., 2007; Ohto 
et al., 2005).  Hepatic tumors, especially hepatocellular carcinoma (HCC), remain one of the 
most commonly encountered diseases worldwide (Bosch et al., 2004), and efficacious 
methods for the diagnosis and therapy of this disease, including CE 3D US imaging, need to 
be explored further (Camaggi et al., 2007; Kudo, 2007; Dietrich, 2002).  
Sonazoid (Daiichi Sankyo, Tokyo, Japan) is a newly-developed second-generation 
ultrasound contrast agent that has been used clinically in Japan since January 2007 for the 
evaluation of liver tumors and for phase-inversion harmonic gray-scale sonography.  
Sonazoid consists of perfluorobutane surrounded by a phospholipid shell and has been 
reported, from previous studies, to be stable enough to allow image acquisition under 
ultrasound exposure for 5 to 10 minutes (Numata et al., 2008; Halpern et al., 2002).    
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Currently, automatically scanned CE 3D US with Sonazoid using the GE LOGIQ 7 
ultrasound system (GE Healthcare, Milwaukee, WI, USA) is being used as a clinical 
diagnostic tool in Japan, especially for liver lesions (Luo et al., 2009a; Luo et al., 2009b; Luo 
et al., 2009c; Luo et al., 2010a; Luo et al., 2010b; Numata et al., 2010a; Numata et al., 2010b).  
With the use of coded harmonic angio (CHA) mode and high mechanical index (MI) 
contrast conditions, which reduce microbubbles in microvessels, but not in relatively large 
vessels, such as tumor vessels and portal veins, CE 3D US with Sonazoid facilitates detailed 
observation of tumor vessels. As compared to CE (two dimensional) US with Sonazoid, 
automatically scanned CE 3D US with Sonazoid allows the volume of interest to be viewed 
in three orthogonal planes, thereby more spatial information and facilitating easier anatomic 
assessment. 
In this chapter, we present the methods used for acquisition and reconstruction of CE 3D US 
images obtained with Sonazoid, and also clinical usefulness of this diagnostic modality in 
the evaluation of hepatic tumor lesions, especially HCC lesions, using many figures to 
facilitate comprehension. 
2. US equipment 
The US scanning was performed with a commercially available ultrasound imaging system 
(LOGIQ 7; GE Healthcare, Milwaukee, WI) and a convex volume 4D3C-L probe with a 
frequency of 2.0-5.5 MHz.   
3. Advantage of Sonazoid over Levovist as a contrast agent for CE 3D US 
In our experience, Levovist is unstable, and therefore, not a suitable contrast agent for CE 
3D US.  As with Levovist, contrast-enhanced US with Sonazoid involves two phases of 
contrast enhancement: the vascular phase and the late (parenchyma-specific, delayed, post-
vascular) phase. The drawback of the poor stability of Levovist is overcome with the high 
stability of Sonazoid and the microbubbles of Sonazoid have the advantage of allowing 
more prolonged imaging and providing stronger contrast effects; hence, more detailed 
observations are possible with Sonazoid than with Levovist.   
4. CE 3D US at a high mechanical index (MI) 
Sonazoid-enhanced US at a low MI using software for a low MI contrast mode (coded phase 
inversion mode: CPI mode) permits visualization of tumor vessels and tumor enhancement 
of liver lesions. However, not only relatively large vessels, such as tumor vessels and portal 
veins, but also microvessels within the liver parenchyma become rapidly filled with 
Sonazoid microbubbles under low MI conditions, which in turn, permits rapid enhancement 
of the tumor and of the liver parenchyma simultaneously. This phenomenon allows only a 
short time for detailed observation of the tumor vessels and tumor enhancement in the 
vascular phase of Sonazoid-enhanced US.   
Sonazoid-enhanced US at a high MI using software for a high MI contrast mode (coded 
harmonic angio mode: CHA mode) allows observation of vessels in the early phase by 
eliminating microbubbles in the microvessels but not in the relatively large vessels, such as 
tumor vessels and portal veins (Numata et al., 2008), which permits a more prolonged of 
observation time of the tumor vessels, clear tumor enhancement, and also automatically 
scanned CE 3D US with Sonazoid.   
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5. Data acquisition 
2D grey-scale US was carried out for identifying the tumor prior to the CE 3D US, and also 
for measurement of the tumor size.  
Prior to the CE 3D US, 0.2 mL Sonazoid was injected as a bolus by hand through an 
antecubital vein, followed by injection of 2 mL of 5% glucose and then a infusion of glucose 
at 10 mL/min.  The coded harmonic angio (CHA) mode with a mechanical index (MI, 0.5-
0.9) of 8 to 13 frames per second was used for the CE US.  The entire contrast procedure was 
divided into three phases: early phase, 15-50 s after injection of the contrast medium; middle 
phase, 80-120 s after injection of contrast medium; late phase, more than 5 minutes after 
injection of contrast medium. 
For data acquisition, the ultrasound imaging system is equipped with two functions: the 
Static 3D function and the Autosweep 3D function. For both functions, the probe held by the 
sonographer automatically sweeps the region in the volume of interest (VOI), the size and 
position of which is already adjusted on the grey-scale US to contain the target tumor and 
the surrounding tissues.  Static 3D enables easy volume scanning and rendering.  However, 
it is difficult to control the complex acoustic power protocol required for high-MI contrast 
imaging, and this may cause unexpected bubble destructions in the middle and late phases.  
On the other hand, the AutoSweep 3D provides the acoustic power control needed for high-
MI imaging, without unexpected bubble destructions. Therefore, in the early phase we 
performed two scanning procedures using the two functions, while in the two subsequent 
phases, only one procedure each was conducted, with the Autosweep 3D. The scanning 
angle can be selected in the range of 15° to 84°.  We used angles in the range of 30°-70°, 
depending on the tumor size.   
When we used the Static 3D for the data acquisition in the early phase, there were five levels 
of acquired image quality, Max, Hi 2, Hi 1, Mid 2, Mid 1, and Low. The Max level combined 
the highest density with the slowest speed, and the Low level combined the lowest density 
with the highest speed. Both the scanning time and image quality should be taken into 
consideration for proper image acquisition. The Mid 2 or Hi1 quality was selected for the 
patients, considering the short breath-holding duration. Accordingly, the time for one 
scanning session was 4.5 s to 26 s (mean 10 s). Therefore, the number of scanning sessions 
was 1 or 2 times during the early phase using the Static 3D function.  The data acquired 
were stored as cineloops in the hard disk of the ultrasound imaging system.  
When we used the Autosweep 3D for data acquisition in each of the three phases, there 
were four levels of acquired image quality, low, mid, high, and max.  The mid quality was 
selected for the patients, considering the short breath-holding duration.  Accordingly, the 
time for one scanning session was 3 s to 11 s (mean 6 s).  The number of scanning sessions 
was 1 to 4 during the early phase, 1 to 2 during the middle phase, and 1 to 4 using the 
Autosweep 3D function. The data acquired were automatically stored as cineloops in the 
hard disk of the ultrasound imaging system. Subsequently, we selected the good data 
obtained in each phase for the image reconstruction. 
6. Image reconstruction 
3D image reconstruction was performed using the functions with which the LOGIQ 7 
ultrasound system was equipped. In the VOI which was presented in an isotropic 
rectangular coordinate frame, the three orthogonal planes were referred to as plane A,  
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Fig. 1. Illustration of the volume of Interest and three orthogonal planes obtained by 
automatic 3D acquisition.  Plane A moves from the front to the rear, or in the opposite 
direction, through the volume of interest, whereas plane B moves from the left to the right, 
or in the opposite direction, and plane C moves from the top to the bottom, or in the 
opposite direction.   
which could migrate from the front to the rear through the VOI, plane B, which moved from 
the left to the right, and plane C, which moved from the top to the bottom (Fig. 1).   
Tomographic ultrasound images (TUI) with presentation of several parallel slices in three 
orthogonal planes were reconstructed in three phases, while the number of slices that could 
be selected was 2, 4, or 6 for images obtained using the Autosweep 3D, and 2, 4, or 9 for the 
Static 3D.  In order to show the desired images, the range of distance between two slices in 
the TUI could be adjusted as required (Figs. 2A-C). The mean time taken for these 
procedures was about 20 s.   
Sonographic angiograms were reconstructed in an angio-like view during the early phase 
using various rendering modes. When the Autosweep 3D was used, the five rendering 
modes consisted of the surface mode, texture mode, and maximum intensity projection 
mode, average intensity mode, and minimum intensity modes, which could be used in any 
combination (Fig. 2D). The maximum intensity projection mode displaying the maximal 
gray values in the VOI, combined with the surface mode displaying the gray values on the 
surfaces of the anatomic structures, was used to visualize the tumor vessels and early tumor 
enhancement in the early phase. While the average intensity mode displaying the average 
gray values in the VOI was employed in combination with the surface mode, to define the 
tumor based on the predominantly unenhanced areas in the early, middle and late phases.  
The mean time taken for these procedures was about 45 s.   
When the Static 3D was used for the reconstruction of the data obtained in the early phase, 
the transparent maximum mode (as same as the maximum intensity projection mode) 
combined with the surface smooth mode was selected to depict the tumor vessels and the 
tumor enhancement distinctly. The transparent X-ray mode (as same as the average 
intensity mode) combined with the surface smooth mode (as same as the surface mode) was 
used for detection of the unenhanced areas within the tumors, if these unenhanced portions 
played an important role in defining the tumors, such as unenhanced portions of metastases  
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Fig. 2. Early-phase contrast-enhanced three-dimensional ultrasonographic (CE 3D US) 
images of the liver in a patient with focal nodular hyperplasia (maximum diameter, 50 mm) 
in the left lobe.  A-C: Tomographic ultrasound images (TUI) in plane A, which could be 
translated from front to back (A), plane B, which could be translated from right to left (B), 
and plane C, which can be translated from bottom to top.  The slice distance is 1.0 mm in 
each plane.  Slight cardiac motion artifacts are seen in planes B and C.  Sonographic 
angiograms acquired by CE 3D US with the Autosweep 3D in the early phase and rendered 
using the maximum intensity projection mode mixed with the surface mode; the images 
show the tumor to contain a spoke-wheel artery (D).  Arrows indicate the spoke-wheel 
artery. 
 
with early peripheral ring-like enhancement accounting for large areas of the tumors. In 
cases of hypervascular tumors, such as typical HCC lesions or focal nodular hyperplasia, the 
transparent maximum mode (maximum intensity projection mode) alone was selected to 
simplify the procedure to depict the intratumoral vessels with early tumor enhancement 
distinctly.  Tortuous vessels within the lesion could be clearly visualized (Fig. 3).  The mean 
time taken for these procedures was about 60 s. 
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Fig. 3. Early-phase of CE 3D US images of the liver in a patient with a large hepatocellular 
carcinoma (HCC) (maximum diameter, 75 mm) in the right lobe.  A-C: Sonographic 
angiograms acquired by CE 3D US with the Static 3D in the early phase and rendered using 
the maximum intensity projection mode alone, presented in different directions, showing 
the tumor containing the tortuous intratumoral vessels.   
7. Characterization of liver lesions by CE 3D US with Sonazoid  
Sonazoid-enhanced 3D US also provides important spatial visualization of any part of the 
VOI. From the early to the late phase, Sonazoid-enhanced 3D US shows tumor vascularity 
and changes in tumor enhancement patterns in multiplanar images. In our retrospective 
study of 139 liver lesions, the diagnostic accuracies of Sonazoid-enhanced 3D US and 
contrast-enhanced 3D CT were assessed for differentiating among liver lesions. The 
sensitivity of both modalities was 83% or higher, the specificity was 87% or higher for 
Sonazoid-enhanced 3D US and 92% or higher for contrast-enhanced 3D CT, the positive 
predictive value was 71% or higher for both modalities, and the area under the receiver 
operating characteristics curve (Az) was 0.89 or more for US and 0.92 or more for CT. The 
inter-reader agreement was good to excellent (κ≥ 0.76) for both modalities (Luo et al., 2009c). 
8. Features of hypervascular HCCs on CE 3D US with Sonazoid  
Typical hypervascular HCCs contain intratumoral vessels and show tumor enhancement in 
the early phase, show homogeneous or heterogeneous tumor enhancement (slight washout) 
in the middle phase, and become hypoechoic, showing a distinct boundary with the 
surrounding liver parenchyma (washout) in the late phase (Figs. 4-6).  Most moderately and 
poorly differentiated HCCs show these enhancement patterns, whereas about half of the 
hypervascular well-differentiated HCCs appear as isoechogenic areas in the late phase. It 
must be borne in mind that about half of the hypervascular well-differentiated HCCs are not 
detected as perfusion defects in the late phase of Sonazoid-enhanced US. 
The main rendering mode used for obtaining sonographic angiograms in the early phase for 
hypervascular HCCs is the maximum intensity projection mode, mixed with some other 
mode at a different percentage, which enables depiction of the tumor staining and tumor 
vessels in three dimensions at any visual angles desired. Sonographic angiograms also 
demonstrate the relationship between the reconstructed tumor staining and the surrounding 
vessels (Figs. 4C, 5A). The main rendering mode used for obtaining sonographic 
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angiograms in the late phase for typical hypervascular HCCs is the average intensity mode 
mixed with the surface mode at a different percentage, which enables depiction of the 
lesions as hypoechogenic (washout) areas. 
 
 
 
 
 
 
 
Fig. 4. CE 3D US images of the liver in a patient with HCC (maximum diameter, 40 mm) 
located adjacent to the left portal vein in segment IV of the left lobe.  A-C: TUI in plane A of 
the early phase (A), middle phase (B), and late phase (C). The slice distance was 3.5 mm in 
each plane. These images show homogeneous tumor enhancement with intratumoral 
vessels in the early phase, homogeneous enhancement (slight washout) in the middle phase, 
and hypoechogenicity (washout) in the late phase.  Sonographic angiograms acquired with 
the Autosweep 3D function in the early phase and rendered using the maximum intensity 
projection mode mixed with the surface mode showing the feeding artery (arrowhead) and 
homogeneous tumor enhancement with intratumoral vessels (arrow) (D).  The left portal 
vein is also seen. 
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Fig. 5. CE 3D US images of the liver in a patient with a small HCC located adjacent to the right 
anterior portal vein (maximum diameter, 13 mm) in segment VIII of the right lobe.  A-D: 
Display of a sonographic angiograms acquired with the Autosweep 3D function in the early 
phase and rendered using the maximum intensity projection mode mixed with the surface 
mode (A) and 3D plane B, which could be translated from right to left (B), plane C, which 
could be translated from bottom to top (C), plane A, which could be translated from front to 
back (D); these images show homogeneous enhancement of the tumor with intratumoral 
vessels adjacent to the portal vein and hepatic artery.  E-H: Display of sonographic angiograms 
acquired with the Autosweep 3D function in the middle phase and rendered using the average 
intensity mode mixed with the surface mode (E) and 3D plane B (F), plane C (G), plane A (H); 
these images exhibit the lesions as perfusion defect.  I-L: Display of sonographic angiograms 
acquired with the Autosweep 3D function in the late phase and rendered using the average 
intensity mode mixed with the surface mode (I) and 3D plane B (J), plane C (K), plane A (L); 
these images exhibit the lesion as a hypoechogenic (washout) area.  Arrowheads indicate the 
margin of the tumor.  Therefore, this HCC shows homogeneous enhancement with 
intratumoral vessels in the early phase, appears as a perfusion defect in the middle phase, and 
as a hypoechogenicity (washout) in the late phase of the CE 3D US. 
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Fig. 6. CE 3D US images of the liver in a patient with a typical hypervascular HCC  
(maximum diameter, 20 mm) in segment VII (arrows) and a non-hypervascular (atypical) 
HCC (maximum diameter, 30 mm) in segment VI (arrowheads) in the right lobe.  A-D: TUI 
in plane A obtained at 22 sec (A) and 37 sec (B) (the early phase), 1 min 45 sec (the middle 
phase) (C), and 6 min 45 sec (the late phase) after injection of Sonazoid (D).  The slice 
distance was 4.4 mm in each plane.  As for the HCC located in segment VII (arrows), the 
tumor shows heterogeneous enhancement with intratumoral vessels in the early phase (A, 
B), homogeneous enhancement (slight washout) in the middle phase (C), and appears as a 
hypoechogenic (washout) area in the late phase (D).  This HCC was a moderately 
differentiated HCC.  As for the HCC located in segment VI (arrowheads), these images 
show hypoechogenicity (A), followed by homogeneous tumor enhancement without 
intratumoral vessels (isoechogenicity) (B) in the early phase, homogeneous enhancement in 
the middle phase (isoechogenicity) (C), and isoechogenicity (persistence of enhancement) in 
the late phase (D).  This HCC was a well-differentiated HCC. 
9. Features of atypical HCCs on CE 3D US with Sonazoid 
Most non-hypervascular well-differentiated HCCs (early HCC) are visualized as hypo- to 
isoechogenic areas without obvious tumor vessels in the early phase, show diffuse 
enhancement in the middle phase (isoechogenicity), and appear as isoechogenic (persistence 
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of enhancement) areas in the late phase.  Figure 6 shows a TUI showing coexistence of 
typical hypervascular HCC and early HCC in the right lobe of the liver. 
Figure 7 shows a nodule-in-nodule type of HCC. A TUI of this lesion shows heterogeneous 
enhancement with intratumoral vessels in the early phase, and heterogeneous enhancement 
in the middle phase. In the late-phase TUI, the lesion exhibits partial hypoechogenicity 
(washout), corresponding to the enhanced area in the early phase, and isoechogencity 
(persistence of enhancement) in the remaining area. In general, isoechogenicity in the late 
phase suggests the diagnosis of well-differentiated HCC and hypoechogenicity in the late 
phase suggests moderately well-differentiated HCC. 
 
 
 
Fig. 7. 3D US and CE 3D US images of the liver in a patient with a nodule-in-nodule type of 
HCC (maximum diameter, 18 mm) in segment VI of the right lobe.  A-D: TUI in plane A of 
B-mode, early phase (A), middle phase (B), and late phase (C). The slice distance was 0.5 
mm in each plane. These images show the nodule-in-nodule lesion in the B-mode (A), 
heterogeneous enhancement with intratumoral vessels in the early phase (B), and 
heterogeneous enhancement in the middle phase (C). In the late-phase TUI, the lesion 
exhibits partial hypoechogenicity (washout), corresponding to the enhanced area in the 
early-phase image, and isoechogenicity (persistence of enhancement) in the remaining area 
(D), corresponding to the non-enhanced area in the early-phase image.  Arrowheads 
indicate the margin of the tumor.   
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10. Features of hepatic metastases on CE 3D US with Sonazoid 
The typical enhancement pattern of hepatic metastases consists of peripheral ring-like 
enhancement with peritumoral vessels (Fig. 8) or intratumoral vessels in the early phase, 
peripheral ring-like enhancement in the middle phase (wash out), and hypoechogenicity 
(wash out) in the late phase. As for hypervascular metastases, CE 3D US shows 
heterogeneous enhancement with intratumoral vessels in the early phase, peripheral ring-
like enhancement (wash out) in the middle phase, and hypoechogenicity (wash out) in the 
late phase (Fig. 9).  In this case, the enhancement pattern in the early phase was consistent 
with that of a hypervascular HCC. However, as compared to a hypervascular HCC, 
hypervascular metastases have a tendency to show an early washout pattern in the middle 
phase. This is a valuable finding for differentiating between these two tumors. 
Hypovascular hepatic metastases show peritumoral vessels without obvious enhancement 
in the early phase, appear as perfusion defects in the middle phase, and show 
hypoechogenicity (washout) in the late phase (Fig. 10). 
 
 
 
Fig. 8. CE 3D US images of the liver in a patient with metastasis from colon carcinoma 
(maximum diameter, 16 mm) in segment VIII of the right lobe.  A-D: TUI in plane A of the 
early phase (A), middle phase (B), and late phase (C). The slice distance was 1.5 mm in each 
plane. These images show peripheral ring-like enhancement with peritumoral vessels in the 
early phase, peripheral ring-like enhancement in the middle phase (wash out), and 
hypoechogenicity (wash out) in the late phase. Arowheads indicate the margin of the tumor.   
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Fig. 9. CE 3D US images of the liver in a patient with metastasis from colon carcinoma 
(maximum diameter, 65 mm) in the right lobe.  A-E: TUI in plane A with a slice distance of 5.4 
mm of the early phase (A), middle phase (B), and late phase (C), in plane B with a slice 
distance of 8.2 mm (D) , and in plane C with a slice distance of 7.0 mm (E) of the late phase.  
These images show heterogeneous enhancement with intratumoral vessels in the early phase 
(A), peripheral ring-like enhancement (wash out) in the middle phase (B), and 
hypoechogenicity (wash out) in the late phase (C-E).  A sonographic angiogram acquired with 
the Autosweep 3D function in the early phase and rendered using the maximum intensity 
projection mode mixed with the surface mode showing heterogeneous tumor enhancement 
with intratumoral vessels (arrow) adjacent to the hepatic artery (F).  A sonographic angiogram 
acquired with the Autosweep 3D function in the late phase and rendered using the average 
intensity mode mixed with the surface mode showing the tumor as a hypoechogenicity (G). 
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Fig. 10. CE 3D US images of the liver in a patient with metastasis from colon carcinoma 
(maximum diameter, 25 mm) in segment VIII in the right lobe. A-C: TUI in plane A of the 
early phase (A), middle phase (B), and late phase (C).  The slice distance was 1.8 mm in each 
plane.  These images show peritumoral vessels alone (arrows), without obvious 
enhancement in the early phase (A), perfusion defect in the middle phase (washout) (B), and 
hypoechogenicity (washout) in the late phase (C). Arrowheads indicate the margin of the 
tumor.  
The main rendering mode used for obtaining sonographic angiograms in the middle and 
late phase for metastases is the average intensity mode, mixed with the surface mode at a 
different percentage, which enables depiction of the lesion as a hypoechogenic (washout) 
region. According to the vascularity in the early phase, we selected the main rendering 
mode for obtaining the sonographic angiograms.  In cases with hypervascular metastases, 
the main rendering mode used is the maximum intensity projection mode, and in cases with 
lesions showing extensive unenhanced areas, we select the average intensity mode as the 
main rendering mode. 
11. Features of hemangiomas on CE 3D US with Sonazoid 
The typical enhancement pattern of a hepatic hemangoma consists of peripheral nodular 
enhancement without tumor vessels in the early phase, peripheral nodular enhancement in 
the middle phase, and isoechogenicity (persistence of enhancement) in the late phase (Fig. 
11). Most hemangiomas appear as isoechogenicities or show incomplete fill-in and  
 
www.intechopen.com
 Ultrasound Imaging 
 
164 
 
 
Fig. 11. CE 3D US images of the liver in a patient with a small hemangioma (maximum 
diameter, 13 mm) in segment VIII of the right lobe.  A-D: TUI in plane A obtained at 21 sec 
(A) and 35 sec (B) (early phase), 1 min 30 sec (middle phase) (C), and 5 min 40 sec (late 
phase) after the injection of Sonazoid (D).  A slice distance is 0.5 mm in each plane.  These 
images show peripheral nodular enhancement without tumor vessels in the early phase (A, 
B), heterogeneous enhancement in the middle phase (C), and isoechogenicity (persistence of 
enhancement) in the late phase (D).  Arrowheads indicate the margin of the tumor. A 
sonographic angiogram acquired with the Autosweep 3D function in the early phase and 
rendered using the average intensity mode mixed with the maximum intensity projection 
mode, presented in different directions, showing peripheral nodular enhancement without 
tumor vessels adjacent to the portal vein and the hepatic artery (E, F).   
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persistence of enhancement in the late phase; however, it must be borne in mind that in 
some cases, these tumors exhibit slight hypoechogenicity (slight washout) in the late phase 
(Fig.12). The enhancement pattern of high-flow type hemangiomas consists of homogeneous 
enhancement immediately after the peripheral nodular enhancement without tumor vessels 
in the early phase, homogeneous enhancement in the middle phase, and isoechogenicity 
(persistence of enhancement) in the late phase. Detection of peripheral nodular 
enhancement without tumor vessels in the early phase is very significant for the diagnosis of 
hemangioma. 
 
 
 
Fig. 12. CE 3D US images of the liver of a patient with hemangioma (maximum diameter, 35 
mm) in segment VIII of the right lobe.  A-C: TUI in plane A of the early phase (A), middle 
phase (B), and late phase (C). The slice distance was 3.5 mm in each plane.  These images 
show peripheral nodular enhancement without tumor vessels in the early phase (A), 
peripheral nodular enhancement in the middle phase (B), and slight hypoechogenicity 
(slight washout) in the late phase (C).  D-G: Display of a sonographic angiogram acquired 
with the Autosweep 3D function in the early phase and rendered using the average intensity 
mode mixed with the maximum intensity projection mode (D) and 3D plane B (E), plane C 
(F), plane A (G).  These images show peripheral nodular enhancement without tumor 
vessels adjacent to the portal vein and the hepatic artery.  H-K: Display of a sonographic 
angiogram acquired with the Autosweep 3D function in the middle phase and rendered 
using the average intensity mode mixed with the surface mode (H) and 3D plane B (I),  
plane C (J), plane A (K).  These images exhibit the lesions as peripheral nodular 
enhancement. 
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The main rendering mode used for obtaining sonographic angiograms in every phase for 
hemangiomas is the average intensity mode, mixed with some other mode at a different 
percentage, which enables depiction of the unenhanced areas of the lesion as a 
hypoechogenic region.   
12. Evaluation of the therapeutic efficacy of ablation therapy by CE 3D US 
with Sonazoid 
 
 
 
 
 
 
Fig. 13. 3D US and CE 3D US images of the liver in a patient with HCC located adjacent to 
the right anterior portal vein (maximum diameter, 29 mm), in segment VIII in the right lobe.    
A-D: Display of sonographic angiograms acquired with the Autosweep 3D function and 
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rendered using the surface mode (A) and 3D plane B, plane C (C), plane A (D) of the B-
mode obtained before RFA showing a hyperechoic tumor.  
E-H: Display of sonographic angiograms acquired with the Autosweep 3D function and 
rendered using the maximum intensity projection mode with the surface mode (E) and 3D 
plane B (F), plane C (G), plane A (H) of the early-phase images obtained before RFA 
showing homogeneous enhancement of the tumor with intratumoral vessels.   
I-L: Display of sonographic angiograms acquired with the Autosweep 3D function and 
rendered using the average intensity with the surface mode (I) and 3D plane B (J), plane C 
(K), plane A (L) of the middle-phase CE 3D US using the CPI mode with a low mechanical 
index obtained 1 day after RFA showing the tumor itself and the ablated areas.  However, 
the background B-mode appears to interfere with the clear visualization of sufficiently 
ablated areas.  
M-P: Display of a sonographic angiograms acquired with the Autosweep 3D function and 
rendered using the average intensity with the surface mode (M) and 3D plane B (N), plane C 
(O), plane A (P) of the middle-phase CE 3D US using the CHA mode with a high mechanical 
index, which eliminates the background B-mode, obtained 1 day after RFA showing the 
necrotic areas as clear perfusion defects.  This 3D view shows that the ablated area is slightly 
larger than the original tumor and that the safety of the margin is not sufficient; thus, the 
patient needed to be monitored closely for tumor recurrence; 22 months after the RFA, local 
recurrence was detected by dynamic MRI. 
 
CE 3D US imaging with Sonazoid allows 3D visualization for comparison with a high 
sensitivity of HCC tumors before treatment with the treated areas after ablation. Use of the 
CHA mode and a high mechanical index eliminates the background B-mode and 
emphasizes the microbubbles in the vessels, allowing residual tumors to be differentiated 
from necrotic areas after ablation. Using this method, we recently demonstrated the 
usefulness of automatically scanned CE 3D US with Sonazoid for early evaluation of the 
therapeutic efficacy of percutaneous RFA for HCC lesions (Fig. 13) (Luo et al., 2010b).  
Sonazoid-enhanced 3D US can also be used to evaluate the immediate therapeutic effects of 
high-intensity focused ultrasound (HIFU) on small HCC lesions. This modality has the 
potential to allow detection of residual HCCs after such treatment, thereby enabling 
additional HIFU ablation to be performed for residual untreated portions (Numata et al., 
2010b). 
13. Side effects of Sonazoid 
Sonazoid is associated with a low incidence of side effects, such as diarrhea 1.6%, 
albuminuria 1.6%, and neutropenia 1.0%. It is not contraindicated for patients with renal 
dysfunction or iodine allergy, although one reported contraindication for Sonazoid in 
patients is a history of egg allergy (Moriyasu & Itoh, 2009).  
14. Limitations 
First, CE 3D US of focal liver lesions has the shortcoming of potentially including artifacts 
from the heart and respiratory movements (Figs. 2B, C), rib cage, and interference from 
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abdominal gas, etc.  We attempted to minimize the influence of artifacts by requesting the 
patients to hold their breath during the scanning procedure, selecting the location of the 
volume transducer, mediating the size and position of the VOI, adjusting the scanning 
angle, and reconstructing the sonographic angiogram using appropriate rendering modes. 
Second, when multiple lesions were detected in one VOI, we could scan the lesions 
simultaneously in the early phase; however, when multiple lesions were located in separate 
VOI, only one VOI could be evaluated by CE 3D US in the early phase.  Third, until recently, 
Sonazoid was only available in Japan, which might the spread of CE 3D US using this 
contrast agent.  
15. Conclusions 
CE 3D US, which is convenient to perform and does not involve radiation exposure, appears 
to be promising as a novel and useful method for three-dimensional evaluation of the 
vascular characteristics of liver tumors and for the differential diagnosis of hepatic lesions 
with good diagnostic capability. These features of CE 3D US are anticipated to be of benefit 
in the clinical setting.  This modality can also be potentially useful for evaluating the effects 
of RF ablation or HIFU for HCCs, offering unique 3D visualization.  We hope that in the 
near future, a fusion imaging method that would allow  fusion and synchronization of CE 
3D US images with multiplanar reconstruction CT or MR images on a single screen in real-
time will become available in the near future. 
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